INDUS Realty Trust, Inc. ("INDUS" or the "Company"), a U.S.-based logistics real estate business, provided a mid-year update ...

Peter McCosker has relocated back to Abu Dhabi, replacing Marcus Hill, who was head of transportation in ADIA’s ...

Global SWF’s recent rankings reflect the shifting dynamics, with GCC funds commanding a larger share of global institutional ...

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Anthem Biosciences' initial public offering (IPO) was subscribed 63.86 times, largely due to strong support from qualified institutional buyers (QIBs).

Anthem Biosciences' IPO is seeing huge demand on its last day. The issue has been subscribed 1,400% so far, showing strong interest from all types of investors. At the same time, the GMP has jumped to ...

Bengaluru-based Anthem Biosciences' initial public offering (IPO) has been subscribed nearly 10 times on its final day, indicating a 27% listing premium.

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 733 against its upper ...

The program aims to prepare 300 students from ADEK Scholarship programs for their upcoming academic journeys abroad ...